{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:15:08Z","timestamp":1794539708883,"version":"4.9.1"},"reference-count":111,"publisher":"Wiley","issue":"8P2","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"vor","delay-in-days":3821,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2001,8]]},"abstract":"<jats:p>The relentless increase of invasive fungal infections and poor outcomes associated with available antifungal agents prompted the search for better therapeutic strategies. Combining antifungal drugs was recommended as a means to enhance efficacy in a variety of invasive infections including cryptococcosis, candidiasis, and aspergillosis. With the exception of cryptococcal meningitis, data from controlled clinical trials supporting such combinations are sparse. Moreover, little consensus exists regarding which combinations are synergistic or antagonistic in vitro and in vivo. Based on available data, several principles underlie these combinations.<\/jats:p>","DOI":"10.1592\/phco.21.12.149s.34505","type":"journal-article","created":{"date-parts":[[2004,6,9]],"date-time":"2004-06-09T05:45:58Z","timestamp":1086759958000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Rationale for Combination Antifungal Therapy"],"prefix":"10.1002","volume":"21","author":[{"given":"Russell E.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197105132841904"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1962.03620240038007"},{"key":"e_1_2_1_4_2","first-page":"197","article-title":"NCCN practice guidelines for fever and neutropenia","volume":"13","author":"National Comprehensive Cancer Network.","year":"1999","journal-title":"Oncology"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/513764"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/520192"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/313746"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/520194"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/513640"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.7.1589"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(08)60129-5"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.2.171"},{"key":"e_1_2_1_13_2","first-page":"473","article-title":"5\u2010Fluorocytosine in human candidiasis","volume":"10","author":"Warner J.F.","year":"1970","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1128\/AAC.43.12.2831","article-title":"Efficacies of high\u2010dose fluconazole plus amphotericin B and high\u2010dose fluconazole plus 5\u2010fluorocytosine versus amphotericin B, fluconazole, and 5\u2010fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans","volume":"43","author":"Louie A.","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_15_2","first-page":"1","article-title":"When and how to treat serious candidal infections: concepts and controversies","volume":"15","author":"Filler S.G.","year":"1995","journal-title":"Curr Clin Top Infect Dis"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809502901007"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199818020-00001"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.4.863"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.mi.48.100194.002351"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/40.5.611"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1999.tb00026.x"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.Supplement_2.S487"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1992.tb02123.x"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(96)92249-5"},{"key":"e_1_2_1_25_2","first-page":"330","volume-title":"Antibiotics in laboratory medicine","author":"Eliopoulos G.M.","year":"1996"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1998.tb00581.x"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.11.2492"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01967067"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.21.6.912"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4644(20000601)77:3<361::AID-JCB2>3.0.CO;2-W"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(99)01731-7"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6343(1998)4:2<135::AID-BSPY6>3.0.CO;2-4"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-3623(96)00220-0"},{"key":"e_1_2_1_34_2","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/iai.58.5.1296-1300.1990","article-title":"In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B","volume":"58","author":"Wolf J.E.","year":"1990","journal-title":"Infect Immunol"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.3109\/08923979109019702"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.1999.00475.x"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1300\/J100v03n04_04"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb00001.x"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70483-9"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.8.1779"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/41.1.59"},{"key":"e_1_2_1_42_2","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/AAC.41.8.1812","article-title":"In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles","volume":"41","author":"Barchiesi F.","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.00013.x"},{"key":"e_1_2_1_44_2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1128\/CDLI.6.6.921-923.1999","article-title":"Successful treatment of fluconazole\u2010resistant oropharyngeal candidiasis by a combination of fluconazole and terbinafine","volume":"6","author":"Ghannoum M.A.","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"e_1_2_1_45_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/AAC.41.2.331","article-title":"Pneumocandin L\u2010743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro","volume":"41","author":"Franzot S.P.","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.5.1070"},{"key":"e_1_2_1_47_2","first-page":"489","article-title":"Antifungal activities of LY 303366 and MK 0991, alone and in combination, against Candida sp and Cryptococcus neoformans [abstr]","volume":"19","author":"Wasson A.","year":"1999","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.11.2518"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.7.2004-2006.2000"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.Supplement_3.S614"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.9.1907"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199039060-00006"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.8.1779"},{"key":"e_1_2_1_54_2","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1128\/AAC.42.6.1382","article-title":"Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model","volume":"42","author":"Lewis R.E.","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/myc.1990.33.7-8.353"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/15.6.1003"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.2.382"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.2.235"},{"key":"e_1_2_1_59_2","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard M27\u2010P","author":"National Committee for Clinical Laboratory Standards.","year":"1998"},{"key":"e_1_2_1_60_2","volume-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; proposed standard M38\u2010P","author":"National Committee for Clinical Laboratory Standards.","year":"1999"},{"key":"e_1_2_1_61_2","unstructured":"LewisR. DiekemaD. MesserS. PfallerM. KlepserM..Comparison of Etest checkerboard dilution and time\u2010kill testing for the detection of synergy or antagonism amongCandidaspecies. Presented at the 39th interscience conference on antimicrobial agents and chemotherapy San Francisco September 2629 1999."},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.10.2915-2918.2000"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(98)00099-6"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.6.1392"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/27.4.491"},{"key":"e_1_2_1_66_2","unstructured":"KlepserM. LewisR. ErnstE. PfallerM..Multicenter evaluation of standardized methods for conducting antifungal time\u2010kill studies. Presented at the 39th interscience conference on antimicrobial agents and chemotherapy San Francisco September 2629 1999."},{"key":"e_1_2_1_67_2","first-page":"45","article-title":"Combination therapy with antifungal drugs","volume":"31","author":"Polak A.","year":"1988","journal-title":"Mycoses"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.11.2459"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.8.1691"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.8.2068-2076.2000"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.4.950-957.2000"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.4.898-904.2000"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.9.2116"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.2.322"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.6.1512"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199324010-00002"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.Supplement_1.S139"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1086\/516284"},{"key":"e_1_2_1_79_2","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1128\/AAC.43.10.2473","article-title":"Use of pharmacodynamic indices to predict efficacy of combination therapy in vivo","volume":"43","author":"Mouton J.W.","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_80_2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1128\/AAC.42.4.744","article-title":"Use of pharmacodynamic parameters to predict efficacy of combination therapy by using fractional inhibitory concentration kinetics","volume":"42","author":"Hollander J.G.","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.5.837"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197907193010303"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199202000-00007"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-3-183"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/19.4.741"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.2.322"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707033370103"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1086\/515110"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.7.1886-1889.1998"},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.3.747-751.2000"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1086\/514504"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.Supplement_2.S89"},{"key":"e_1_2_1_93_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/32.1.5"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1086\/313749"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01713042"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01728917"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90481-6"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.110.6.1507"},{"key":"e_1_2_1_99_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.2.310"},{"key":"e_1_2_1_100_2","doi-asserted-by":"publisher","DOI":"10.1086\/513943"},{"key":"e_1_2_1_101_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.3.608"},{"key":"e_1_2_1_102_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/12.6.1147"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1177\/000348949910800218"},{"key":"e_1_2_1_104_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.19.1.118.30511"},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003163421102"},{"key":"e_1_2_1_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1201-9712(99)90038-3"},{"key":"e_1_2_1_107_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200007000-00006"},{"key":"e_1_2_1_108_2","unstructured":"HachemR. AfifC. CooksleyC. et al.Invasive aspergillosis in cancer patients: poor outcome despite aggressive therapy. Presented at the 42nd annual meeting of the American Society of Hematology San Francisco December 15 2000."},{"key":"e_1_2_1_109_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549609027182"},{"key":"e_1_2_1_110_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1987.tb03632.x"},{"key":"e_1_2_1_111_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00441214"},{"key":"e_1_2_1_112_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/41.suppl_4.13","article-title":"Science and pragmatism in the treatment and prevention of neutropenic infection","volume":"41","author":"Klastersky J.","year":"1998","journal-title":"J Antimicrob Chemother"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.21.12.149S.34505","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.21.12.149S.34505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:13:51Z","timestamp":1761041631000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.21.12.149S.34505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":111,"journal-issue":{"issue":"8P2","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["10.1592\/phco.21.12.149S.34505"],"URL":"https:\/\/doi.org\/10.1592\/phco.21.12.149s.34505","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8]]},"assertion":[{"value":"2012-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}